Spina E - Search Results

1

Acute cerebellar ataxia following meningococcal group C conjugate vaccination.

Cutroneo PM, Italiano D, Trifirò G, Tortorella G, Russo A, Isola S, Caputi AP, Spina E. Cutroneo PM, et al. Among authors: spina e. J Child Neurol. 2014 Jan;29(1):128-30. doi: 10.1177/0883073812469724. Epub 2012 Dec 28. J Child Neurol. 2014. PMID: 23275434

2

Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects.

Spina E, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Eur J Clin Pharmacol. 1992;42(3):347-8. doi: 10.1007/BF00266363. Eur J Clin Pharmacol. 1992. PMID: 1349529 No abstract available.

3

Interaction between fluvoxamine and imipramine/desipramine in four patients.

Spina E, Campo GM, Avenoso A, Pollicino MA, Caputi AP. Spina E, et al. Ther Drug Monit. 1992 Jun;14(3):194-6. doi: 10.1097/00007691-199206000-00004. Ther Drug Monit. 1992. PMID: 1412604

4

Debrisoquine oxidation phenotype and neuroleptic-induced dystonic reactions.

Spina E, Sturiale V, Valvo S, Ancione M, Di Rosa AE, Meduri M, Caputi AP. Spina E, et al. Acta Psychiatr Scand. 1992 Nov;86(5):364-6. doi: 10.1111/j.1600-0447.1992.tb03281.x. Acta Psychiatr Scand. 1992. PMID: 1485526

5

Debrisoquine oxidation phenotype during neuroleptic monotherapy.

Spina E, Martines C, Caputi AP, Cobaleda J, Piñas B, Carrillo JA, Benitez J. Spina E, et al. Eur J Clin Pharmacol. 1991;41(5):467-70. doi: 10.1007/BF00626371. Eur J Clin Pharmacol. 1991. PMID: 1684751

6

Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.

Spina E, Campo GM, Calandra S, Caputi AP, Carrillo JA, Benitez J. Spina E, et al. Pharmacol Res. 1992 Jan;25(1):43-50. doi: 10.1016/s1043-6618(05)80063-5. Pharmacol Res. 1992. PMID: 1738757

7

Debrisoquine oxidation in schizophrenic patients treated with neuroleptics.

Spina E, Buemi AL, Caputi AP, Benitez J, Cobaleda J, Garcia MA, Llerena A, Piña B. Spina E, et al. Pharmacol Res Commun. 1988 Dec;20(12):1103-4. doi: 10.1016/s0031-6989(88)80747-1. Pharmacol Res Commun. 1988. PMID: 2905478 No abstract available.

8

The effect of carbamazepine on the 2-hydroxylation of desipramine.

Spina E, Avenoso A, Campo GM, Caputi AP, Perucca E. Spina E, et al. Psychopharmacology (Berl). 1995 Feb;117(4):413-6. doi: 10.1007/BF02246212. Psychopharmacology (Berl). 1995. PMID: 7604141

9

Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients.

Spina E, De Domenico P, Ruello C, Longobardo N, Gitto C, Ancione M, Di Rosa AE, Caputi AP. Spina E, et al. Int Clin Psychopharmacol. 1994 Winter;9(4):281-5. doi: 10.1097/00004850-199400940-00007. Int Clin Psychopharmacol. 1994. PMID: 7868850 Clinical Trial.

10

Iron status in schizophrenic patients with acute neuroleptic-induced dystonic reactions.

Spina E, Ancione M, Di Rosa AE, Artemisia A, Natoli C, Caputi AP. Spina E, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Sep;18(5):891-8. doi: 10.1016/0278-5846(94)90105-8. Prog Neuropsychopharmacol Biol Psychiatry. 1994. PMID: 7972859 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters